BioSyent Inc. (CVE:RX - Get Free Report) insider BioSyent Inc. acquired 5,100 shares of the stock in a transaction on Monday, April 29th. The shares were bought at an average cost of C$8.55 per share, for a total transaction of C$43,627.95.
BioSyent Trading Down 1.6 %
Shares of RX stock opened at C$8.51 on Thursday. The company has a debt-to-equity ratio of 3.51, a quick ratio of 6.91 and a current ratio of 6.48. BioSyent Inc. has a fifty-two week low of C$7.03 and a fifty-two week high of C$9.26. The stock has a market capitalization of C$98.80 million, a P/E ratio of 16.06 and a beta of 0.93. The company has a 50 day moving average price of C$8.61 and a 200 day moving average price of C$8.54.
BioSyent (CVE:RX - Get Free Report) last released its quarterly earnings results on Wednesday, March 13th. The company reported C$0.12 EPS for the quarter, missing the consensus estimate of C$0.17 by C($0.05). BioSyent had a return on equity of 18.97% and a net margin of 20.45%. The company had revenue of C$8.27 million for the quarter, compared to analysts' expectations of C$8.80 million. Equities research analysts predict that BioSyent Inc. will post 0.4695983 EPS for the current fiscal year.
BioSyent Company Profile
(
Get Free Report)
Elon to Transform U.S. Economy?
From Porter & Company | Ad
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
One company holds a near-total monopoly on it.
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
